CLINICAL_TRIALS
trial_result
· 2013-12-09
Clinical Trial Update: Expanded Access Study Of BEXXAR® For Low Grade And Transformed Low-Grade Non-Hodgkin's Lymphoma [Phase 2]
Summary
Phase 2 expanded-access study of BEXXAR for low-grade and transformed low-grade non-Hodgkin lymphoma completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Lymphoma, Non-Hodgkin | Phase 2 | Status: COMPLETED | Results posted: 2013-12-09